Bayer AG, founded in 1863 and headquartered in Leverkusen, Germany, is a global leader in the life sciences sector, with a strong focus on health care and agriculture. The company's diverse portfolio includes pharmaceuticals, consumer health products, and crop science solutions, aiming to improve the quality of life for people worldwide.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Bayer has a well-established presence in the bond market, having begun its bond issuance activities in the early 20th century. Notable issuances include its €1 billion green bond launched in 2020, part of its commitment to sustainability and reducing environmental impacts. Currently, Bayer's bonds yield comparably to industry averages, reflecting investor confidence despite market fluctuations. Recent news highlights Bayer's refinancing efforts to support strategic acquisitions and innovation initiatives, further demonstrating its commitment to growth and stability.